Benzinga's Top #PreMarket Gainers

By: via Benzinga
Conatus Pharmaceuticals Inc (NASDAQ: CNAT) shares rose 25.44 percent to $7.20 in pre-market trading after the company reported ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.